chartexchange

Prologue Medicines Appoints Stephen Harrison, Ph.D., as Chief Scientific Officer

PR Newswire | Oct 13, 2026 10:00 AM EDT

Company also welcomes Jason Silvers, President and CFO of Generate Biomedicines, and Adrian Rawcliffe, CEO-Partner at Flagship Pioneering and CEO of Etiome, to its Board of Directors CAMBRIDGE, Mass., Oct. 13, 2026 /PRNewswire/ -- Prologue Medicines, a biotechnology company unlocking the...

Read original article